低氧诱导的血小板源性PDGFA促进胆道闭锁中肝脏病理性微血管新生的机制研究
批准号:
32100956
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
文莹
依托单位:
学科分类:
病理生理学
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
文莹
中文摘要
病理性血管新生是加重肝胆疾病纤维化的关键诱因,然而其对胆道闭锁(BA)的病理学意义及防治尚缺乏深入研究。我们以BA患儿肝脏处于低氧微环境为切入点,预实验结果发现BA中血小板过度活化及其PDGFA表达升高,并可促进微血管新生;继而蛋白质组学乳酸化修饰分析及细胞学实验结果显示,BA血小板上与激活相关的膜蛋白乳酸化修饰水平增加。据此我们提出BA中血管病理学特征形成的新机制:低氧可致血小板转向糖酵解,细胞内乳酸蓄积,诱导靶蛋白乳酸化修饰增强而激活血小板,增加其分泌PDGFA进而促进BA中肝脏血管新生。本课题拟通过BA模型和血小板条件敲除PDGFA小鼠,深入探讨低氧诱导血小板乳酸化修饰改变而激活的具体机制,进一步验证分泌的血小板源PDGFA具有促进BA疾病模型中血管新生的新功能,为阐明BA血管病理学特征形成提供新的理论依据,为BA的早期诊断和靶向治疗提供新的思路。
英文摘要
Pathological angiogenesis is the key cause of aggravating hepatobiliary fibrosis, but its pathological significance and prevention of biliary atresia (BA) still lack in-depth studies. Taken the liver of BA in a hypoxic microenvironment as the starting point,we have recently observed that overactivated platelets increase the expression of PDGFA and promote the pathological micro-angiogenesis. Further proteomics analysis of lactylation and cytological experiment results show that the platelets activation-related membrane protein increase the modification of lactylation in BA. Based on this, we propose a new mechanism of BA vascular pathology: Platelet will turn to glycolysis in hypoxia, leading to the accumulation of lactate, that could induce platelets activation due to the enhanced lactylation of platelet-target, thereby increasing its secretion of PDGFA to promote liver angiogenesis in BA. Through BA mouse model or KO-PDGFA gene mice of conditional-platelets, this project intends to explore the specific regulation mechanism of platelet activation induced by hypoxia-induced lactylation, and further verify the secreted platelet-derived PDGFA has a new function to promote angiogenesis in BA model. Thus, this project provides a new theory for pathological neovascularization in biliary atresia, which may develop into a new diagnostic and therapeutic idea for biliary atresia.
胆道闭锁(Biliary atresia,BA)是一种以肝内外胆道闭塞为特征可导致进行性肝纤维化的严重肝胆系统疾病,其基本病理特征为肝内进行性炎症及血管新生、肝纤维化,最终导致肝硬化和门脉高压,甚至肝功能衰竭。但是,迄今为止于BA确切病因不清,病情进展快,临床病理特征复杂且有待深入研究,使其治疗手段十分有限。因此,寻找其潜在的致病机制和病理特征,早期积极抗炎治疗,是改善BA患儿预后的重要临床问题。本项目研究发现,BA肝脏处于低氧微环境,可促进血小板活化且可发生乳酸化修饰;体内外实验验证,BA中活化血小板可激活中性粒细胞诱导胞外诱捕网(neutrophil extracellular traps, NETs)形成;进一步,BA血浆单细胞测序及流式检测发现血小板功能紊乱,机制上通过投射电镜及免疫荧光检测发现血小板可能释放氧化线粒体DNA而促进NETs的形成,从而释放炎症因子(TNFα/IL-1β/IL6)加重肝内进行性炎症及血管新生。此外,NETs形成后释放炎症相关因子S100A8/S100A9,进一步形成回路激活血小板。我们的研究解析了BA患儿中活化的血小板可通过释放氧化线粒体DNA诱导中性粒细胞激活并释放NETs,促使炎症级联反应及血管新生,最终导致BA发生发展的分子机制,为阐明BA的病理特征提供新的理论依据,为其早期诊断和靶向治疗提供新的思路。
国内基金
海外基金